{"id":28137,"date":"2024-03-22T19:52:35","date_gmt":"2024-03-22T23:52:35","guid":{"rendered":"https:\/\/www.ipoboutique.com\/blog\/?p=28137"},"modified":"2024-03-22T19:52:35","modified_gmt":"2024-03-22T23:52:35","slug":"friday-pipeline-update-three-deals-file-as-pipeline-begins-to-awaken","status":"publish","type":"post","link":"https:\/\/www.ipoboutique.com\/blog\/friday-pipeline-update-three-deals-file-as-pipeline-begins-to-awaken\/","title":{"rendered":"Friday Pipeline Update: Three deals file as pipeline begins to awaken"},"content":{"rendered":"<p><b><u>NEW FILINGS<\/u><\/b><\/p>\n<div><b><u>\u00a0<\/u><\/b><\/div>\n<div>\n<p dir=\"ltr\">Company: \u00a0Contineum Therapeutics, Inc.<\/p>\n<p dir=\"ltr\">Symbol: CTNM (Nasdaq)<\/p>\n<p dir=\"ltr\">Description:\u00a0 They are a clinical stage biopharmaceutical company focused on discovering and developing novel, oral small molecule therapies that target biological pathways associated with specific clinical impairments for the treatment of neuroscience, inflammation and immunology (NI&amp;I) indications with high unmet need.<\/p>\n<p dir=\"ltr\">Shares: TBD<\/p>\n<p dir=\"ltr\">Price Range: TBD<\/p>\n<p dir=\"ltr\">Trade Date:\u00a0 TBD<\/p>\n<p dir=\"ltr\">Underwriter(s): Goldman Sachs, Morgan Stanley, Stifel, RBC Capital<\/p>\n<p dir=\"ltr\">Link to Prospectus: <a href=\"https:\/\/www.sec.gov\/Archives\/edgar\/data\/1855175\/000119312524069256\/d578485ds1.htm\">Filed: 3-15-24<\/a><\/p>\n<p dir=\"ltr\"><img decoding=\"async\" src=\"https:\/\/lh7-us.googleusercontent.com\/InUjLtD2IipAOawpCcdJ_3vmDazSyTRkwg4L5mzfymMq8tuJeg0zia7YyXDVdRe9Y_zidUZwl5PEMnZZWT2jfp0Smp2UYNBp63JP3d4_xZ304baYx5nySDdThKLKSzx8qf-puQQOJR_mSB1C1VHT8ZI\" width=\"369\" height=\"97\" \/><\/p>\n<p><span id=\"gmail-docs-internal-guid-d33b397f-7fff-0f38-2aaf-df8e9475b8a3\"><br \/>\n<\/span><\/p>\n<p dir=\"ltr\">Company: \u00a0Centuri Holdings, Inc.<\/p>\n<p dir=\"ltr\">Symbol: CTRI (NYSE)<\/p>\n<p dir=\"ltr\">Description:\u00a0 Centuri is a leading, pure-play North American utility infrastructure services company with over 110 years of operating history that partners with regulated utilities to maintain, upgrade and expand the energy network that powers millions of homes and businesses.<\/p>\n<p dir=\"ltr\">Shares: TBD<\/p>\n<p dir=\"ltr\">Price Range: TBD<\/p>\n<p dir=\"ltr\">Trade Date:\u00a0 TBD<\/p>\n<p dir=\"ltr\">Underwriter(s): UBS Investment Bank, BofA Securities, J.P. Morgan, Wells Fargo Securities<\/p>\n<p dir=\"ltr\">Co-Manager(s): Baird, KeyBanc Capital, Siebert Williams Shank<\/p>\n<p dir=\"ltr\">Link to Prospectus: <a href=\"https:\/\/www.sec.gov\/Archives\/edgar\/data\/1981599\/000119312524075215\/d507887ds1.htm\">Filed: 3-22-24<\/a><\/p>\n<p dir=\"ltr\"><img decoding=\"async\" src=\"https:\/\/lh7-us.googleusercontent.com\/Uyl-KnjAKgGu33xq7WK46aiR4iK39yWv46mniirnfs8-o2WH1JGGGCSe16wG4LYz-UQG-ZxFAl3hbNo_nSQK3J4iw8osvU8zy6XpM0876as_5S3-cGhU7kf62rkJla7F7IcftsSGJVHCWgFyxbwUTdc\" width=\"310\" height=\"81\" \/><\/p>\n<p dir=\"ltr\">Company: \u00a0Ibotta, Inc.<\/p>\n<p dir=\"ltr\">Symbol: IBTA (NYSE)<\/p>\n<p dir=\"ltr\">Description:\u00a0 Ibotta\u2019s mission is to Make Every Purchase Rewarding. Their technology allows CPG brands to deliver digital promotions to over 200 million consumers through a single, convenient network called the Ibotta Performance Network (IPN).<\/p>\n<p dir=\"ltr\">Shares: TBD<\/p>\n<p dir=\"ltr\">Price Range: TBD<\/p>\n<p dir=\"ltr\">Trade Date:\u00a0 TBD<\/p>\n<p dir=\"ltr\">Underwriter(s): Goldman Sachs, Citigroup, BofA Securities, Evercore ISI, UBS Investment Bank, Wells Fargo Securities<\/p>\n<p dir=\"ltr\">Co-Manager(s): Citizens JMP, Needham &amp; Co., Raymond James<\/p>\n<p dir=\"ltr\">Link to Prospectus: <a href=\"https:\/\/www.sec.gov\/Archives\/edgar\/data\/1538379\/000162828024012708\/ibottas-1.htm\">Filed: 3-22-24<\/a><\/p>\n<p dir=\"ltr\"><img decoding=\"async\" src=\"https:\/\/lh7-us.googleusercontent.com\/GTTDfF55xFi2STnG9AUb3htJ6--AA3guT6PfiuhtZcfbLFSTHc1QRBI5JLQbi0os-z2rqMpBnyu3_8zCDCScAsvN-4pHUEF7Z2jzOg_-_k_WZi8EOw1NngMxV6qXZUOjkD_F_mZNXgXt7ffeoTnnqSg\" width=\"317\" height=\"93\" \/><\/p>\n<\/div>\n<div><\/div>\n<div><b><u>TERMS ADDED<\/u><\/b><\/div>\n<div><b><u>\u00a0<\/u><\/b><\/div>\n<div>\n<p dir=\"ltr\">Company: \u00a0Boundless Bio, Inc.<\/p>\n<p dir=\"ltr\">Symbol: BOLD (Nasdaq)<\/p>\n<p dir=\"ltr\">Description:\u00a0 They are a clinical-stage oncology company dedicated to unlocking a new paradigm in cancer therapeutics that addresses the significant unmet need in patients with oncogene amplified tumors by targeting extrachromosomal DNA (ecDNA), a root cause of oncogene amplification observed in more than 14% of cancer patients.<\/p>\n<p dir=\"ltr\">Shares: 6.25 million<\/p>\n<p dir=\"ltr\">Price Range: $15.00-$17.00<\/p>\n<p dir=\"ltr\">Market Cap: $334m-$378m<\/p>\n<p dir=\"ltr\">Trade Date:\u00a0 Thursday, 3\/28<\/p>\n<p dir=\"ltr\">Underwriter(s): Goldman Sachs, Leerink Partners, Piper Sandler, Guggenheim Securities<\/p>\n<p dir=\"ltr\">Link to Prospectus: <a href=\"https:\/\/www.sec.gov\/Archives\/edgar\/data\/1782303\/000119312524073230\/d493037ds1a.htm\">Terms Added: 3-21-24<\/a><\/p>\n<p dir=\"ltr\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/lh7-us.googleusercontent.com\/JfdfuNdok5RGfSdQJjMEbBHIW7Td6NeQ98a1saXOaeG8zuQ5EAFlolNfKdUfQ9SEGrBXci-bWNvKgJwgKHp6oQLFKwBQOR1cXzaMeKyVqk2Rffm8P9b3yNcpAiEVJWCWKUzO-hVnlgyQAlMYe5hmDUI\" width=\"417\" height=\"61\" \/><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>NEW FILINGS \u00a0 Company: \u00a0Contineum Therapeutics, Inc. Symbol: CTNM (Nasdaq) Description:\u00a0 They are a clinical stage biopharmaceutical company focused on discovering and developing novel, oral small molecule therapies that target biological pathways associated with specific clinical impairments for the treatment of neuroscience, inflammation and immunology (NI&amp;I) indications with high unmet need. Shares: TBD Price Range:[&hellip;]<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"zakra_general_container_width":0,"zakra_general_content_width":0,"zakra_general_sidebar_width":0,"zakra_sticky_header":"customizer","zakra_header_main_area":true,"zakra_site_logo_width":0,"zakra_header_top_enabled":"customizer","zakra_header_top_style":"customizer","zakra_primary_menu_item_style":"customizer","zakra_page_header_text_color":"","zakra_page_header_layout":"customizer","zakra_page_title_bg":null,"zakra_footer_widgets_bg_image":0,"zakra_page_title_bg_repeat":"customizer","zakra_page_title_bg_position":"customizer","zakra_page_title_bg_size":"customizer","zakra_page_title_bg_attachment":"customizer","zakra_breadcrumbs_enabled":"customizer","zakra_breadcrumbs_text_color":null,"zakra_breadcrumbs_separator_color":null,"zakra_breadcrumbs_link_color":null,"zakra_breadcrumbs_link_hover_color":"","zakra_page_title_bg_image":0,"zakra_footer_widgets_enabled":"customizer","zakra_footer_column_layout_1_style":"customizer","zakra_footer_widgets_bg":"","zakra_footer_widgets_bg_repeat":"customizer","zakra_footer_widgets_bg_position":"customizer","zakra_footer_widgets_bg_size":"customizer","zakra_footer_widgets_bg_attachment":"customizer","zakra_footer_bar_enabled":"customizer","zakra_footer_bar_style":"customizer","footnotes":""},"categories":[1536],"tags":[],"class_list":["post-28137","post","type-post","status-publish","format-standard","hentry","category-subscriber-content"],"_links":{"self":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/28137","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/comments?post=28137"}],"version-history":[{"count":1,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/28137\/revisions"}],"predecessor-version":[{"id":28138,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/28137\/revisions\/28138"}],"wp:attachment":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/media?parent=28137"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/categories?post=28137"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/tags?post=28137"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}